Jump Financial’s ProShares Ultra CRCL CRCA Stock Holding History

Jump Financial’s Portfolio CRCA Stock Details CRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,144	Closed	-$248K	–	2534
2025 Q4	$248K	Buy	6,144 +4,333	+239%	+$372K	﹤0.01%	1642
2025 Q3	$265K	Buy	+1,811	New	+$291K	﹤0.01%	1547

Other funds holding CRCA

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Jump Financial's CRCA Position: Q1 2026 in Review

Jump Financial sold out of ProShares Ultra CRCL (CRCA) in Q1 2026, closing a stake of 6,144 shares — an estimated $248K sold.

Jump Financial first reported a position in CRCA in Q3 2025 and held it in 2 quarters. The position peaked at $265K in Q3 2025. 7 funds tracked by Wall St. Rank hold CRCA as of Q1 2026.

Jump Financial reported no remaining ProShares Ultra CRCL position as of Q1 2026 after selling out during the quarter.
Jump Financial sold 6,144 ProShares Ultra CRCL shares in Q1 2026, an estimated $248K.
Jump Financial first reported a position in ProShares Ultra CRCL in Q3 2025 and held it in 2 quarters.
Jump Financial's ProShares Ultra CRCL position peaked at $265K in Q3 2025.
7 funds tracked by Wall St. Rank held ProShares Ultra CRCL as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.